BackgroundColorectal cancer (CRC) is a heterogeneous disease. and current classification systems are insufficient for stratifying patients with different risks. This study aims to develop a generalized. individualized prognostic consensus molecular subtype (CMS)-transcription factors (TFs)-based signature that can predict the prognosis of CRC. https://bbmbatteryes.shop/product-category/124/